These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

472 related items for PubMed ID: 11410498

  • 1. Defective transforming growth factor beta signaling pathway in head and neck squamous cell carcinoma as evidenced by the lack of expression of activated Smad2.
    Muro-Cacho CA, Rosario-Ortiz K, Livingston S, Muñoz-Antonia T.
    Clin Cancer Res; 2001 Jun; 7(6):1618-26. PubMed ID: 11410498
    [Abstract] [Full Text] [Related]

  • 2. Differences in Smad4 expression in human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck squamous cell carcinoma.
    Báez A, Cantor A, Fonseca S, Marcos-Martinez M, Mathews LA, Muro-Cacho CA, Muñoz-Antonia T.
    Clin Cancer Res; 2005 May 01; 11(9):3191-7. PubMed ID: 15867212
    [Abstract] [Full Text] [Related]

  • 3. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV, Gama P, Wen X, Demopoulos R, Munger JS, Carcangiu ML, Reiss M, Gold LI.
    Cancer Res; 2002 May 15; 62(10):2778-90. PubMed ID: 12019154
    [Abstract] [Full Text] [Related]

  • 4. Transforming growth factor-beta type II receptors and smad proteins in follicular thyroid tumors.
    West J, Munoz-Antonia T, Johnson JG, Klotch D, Muro-Cacho CA.
    Laryngoscope; 2000 Aug 15; 110(8):1323-7. PubMed ID: 10942134
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. TGF-beta signaling is disrupted in endometrioid-type endometrial carcinomas.
    Piestrzeniewicz-Ulanska D, Brys M, Semczuk A, Rechberger T, Jakowicki JA, Krajewska WM.
    Gynecol Oncol; 2004 Oct 15; 95(1):173-80. PubMed ID: 15385128
    [Abstract] [Full Text] [Related]

  • 12. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.
    Wang D, Kanuma T, Mizunuma H, Takama F, Ibuki Y, Wake N, Mogi A, Shitara Y, Takenoshita S.
    Cancer Res; 2000 Aug 15; 60(16):4507-12. PubMed ID: 10969799
    [Abstract] [Full Text] [Related]

  • 13. Mutational analysis of TGF-beta type II receptor, Smad2, Smad3, Smad4, Smad6 and Smad7 genes in colorectal cancer.
    Fukushima T, Mashiko M, Takita K, Otake T, Endo Y, Sekikawa K, Takenoshita S.
    J Exp Clin Cancer Res; 2003 Jun 15; 22(2):315-20. PubMed ID: 12866583
    [Abstract] [Full Text] [Related]

  • 14. The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer.
    Kleeff J, Ishiwata T, Maruyama H, Friess H, Truong P, Büchler MW, Falb D, Korc M.
    Oncogene; 1999 Sep 23; 18(39):5363-72. PubMed ID: 10498890
    [Abstract] [Full Text] [Related]

  • 15. Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma.
    Liu X, Lee J, Cooley M, Bhogte E, Hartley S, Glick A.
    Cancer Res; 2003 Nov 15; 63(22):7760-8. PubMed ID: 14633701
    [Abstract] [Full Text] [Related]

  • 16. Activin type II receptor restoration in ACVR2-deficient colon cancer cells induces transforming growth factor-beta response pathway genes.
    Deacu E, Mori Y, Sato F, Yin J, Olaru A, Sterian A, Xu Y, Wang S, Schulmann K, Berki A, Kan T, Abraham JM, Meltzer SJ.
    Cancer Res; 2004 Nov 01; 64(21):7690-6. PubMed ID: 15520171
    [Abstract] [Full Text] [Related]

  • 17. Prognostic value of the expression of Smad6 and Smad7, as inhibitory Smads of the TGF-beta superfamily, in esophageal squamous cell carcinoma.
    Osawa H, Nakajima M, Kato H, Fukuchi M, Kuwano H.
    Anticancer Res; 2004 Nov 01; 24(6):3703-9. PubMed ID: 15736400
    [Abstract] [Full Text] [Related]

  • 18. Activation of Smad signaling enhances collagenase-3 (MMP-13) expression and invasion of head and neck squamous carcinoma cells.
    Leivonen SK, Ala-Aho R, Koli K, Grénman R, Peltonen J, Kähäri VM.
    Oncogene; 2006 Apr 27; 25(18):2588-600. PubMed ID: 16407850
    [Abstract] [Full Text] [Related]

  • 19. Regulation of transforming growth factor-beta signaling.
    Zhu HJ, Burgess AW.
    Mol Cell Biol Res Commun; 2001 Nov 27; 4(6):321-30. PubMed ID: 11703090
    [Abstract] [Full Text] [Related]

  • 20. Smad proteins and hepatocyte growth factor control parallel regulatory pathways that converge on beta1-integrin to promote normal liver development.
    Weinstein M, Monga SP, Liu Y, Brodie SG, Tang Y, Li C, Mishra L, Deng CX.
    Mol Cell Biol; 2001 Aug 27; 21(15):5122-31. PubMed ID: 11438667
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.